Anti-AGO2 antibody, Mouse monoclonal (mouse IgG1 isotype) is derived from the AGO2-10 hybridoma produced by the fusion of mouse myeloma cells and splenocytes from a BALB/c mouse immunized with synthetic peptide from the C-terminal region of human AGO2 protein, conjugated to keyhole limpet hemocyanin (KLH). AGO2 is also known as protein argonaute 2, argonaute RNA-induced silencing complex (RISC) catalytic component 2, eukaryotic translation initiation factor 2C 2 (eIF2C2) and PAZ Piwi domain protein (PPD). Argonaute 2 (AGO2) belongs to the Argonaute family. It is located on human chromosome 8q24. Ago proteins localize to the cytoplasm of somatic cells and are concentrated in cytoplasmic processing bodies.
Synonyms: Anti-Argonaute RISC catalytic component 2; Anti-Argonaute2; Anti-Eukaryotic translation initiation factor 2C 2; Anti-PAZ Piwi domain protein (PPD); Anti-Protein Argonaute 2; Anti-eIF2C 2
Storage: -20C
Application: Anti-AGO2 antibody, Mouse monoclonal has been used in immunoblotting and immunoprecipitation.
Biochem Physiol Actions: Argonaute 2 (AGO2) exhibits intrinsic endonuclease activity. It can directly cleave mRNAs in a small RNA-guided manner. AGO2 plays a central role in RNA silencing processes as essential catalytic components of the RNA-induced silencing complex (RISC). It has an important role in stabilization of circulating microRNAs (miRNAs) in exosomes from extracellular body fluids.